Document is current
Any future updates will be listed below
-
Authors
Van Regenmortel, Niels https://orcid.org/0000-0002-8746-2325
Jorens, Philippe G.
-
Funding
Funding for this research was provided by:
Baxter Healthcare Corporation
- License Information
-
More Information
Article History
Accepted: 23 February 2020
First Online: 11 March 2020
Compliance with ethical standards
:
: Dr Van Regenmortel reports speaker’s fees from Baxter Healthcare Corporation and was member of an advisory board on fluid therapy organized by this company in 2017. He is the co-chairman and the co-founder of the International Fluid Academy (IFA), a nonprofit organization promoting education on fluid management and hemodynamic monitoring that received unrestricted educational grants from the industry (). Dr Jorens has nothing to disclose.
: The TOPMAST study was approved by the hospital’s Institutional Review Board (reference number 17/04/034). The trial was registered at ClinicalTrials.gov (NCT03080831) and its protocol prepublished.
